Liposome battle for antifungal market shifts into high gear.
Marks
S
S
D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004304:Dosage Forms; D017277:Drug Approval; D006801:Humans; D016867:Immunocompromised Host; D009181:Mycoses / Q000150:complications / Q000188:drug therapy*
D000935:Antifungal Agents; D004304:Dosage Forms; D000666:Amphotericin B